Related by context. Frequent words. (Click for all words.) 73 BEMA TM Fentanyl 68 Kuvan R 67 pseudobulbar affect PBA 67 GEM #S 67 TRANSDUR Sufentanil 66 Copegus R 66 R sorafenib tablets 66 topical anti infective 65 Aloxi R 65 Receives Orphan Drug Designation 65 Release Tablets 65 Argatroban 65 Onalta 65 Panzem R 65 BEMA Fentanyl 65 Advancing Drugs 64 R bortezomib 64 NEBIDO R 64 candidate brentuximab vedotin 64 Ciclesonide 64 Surgical Adhesive 64 Nebido 64 TELINTRA 63 Octreotide 63 ABILIFY R 63 Application MAA 63 Soliris TM eculizumab 63 ZALBIN 63 Xyntha 63 Visudyne R 63 gets USFDA nod 63 Abstral 63 Vitaros ® 63 Generic Version 63 Ticagrelor 63 monobasic monohydrate USP 63 VALSTAR 63 ELADUR 63 Ranexa R 62 BioGlue R 62 candidates bavituximab 62 phenylketonuria PKU developed 62 Pirfenidone 62 Stavzor 62 Proxinium TM 62 Initiates Phase II 62 ONSOLIS 62 FDA Accepts 62 Gemzar ® 62 Meets Primary Endpoint 62 Eligard R 62 refractory chronic lymphocytic 62 Nexavar ® 62 Bone Graft 62 Icatibant 62 BEMA Buprenorphine 62 Testim R 62 Ondansetron 61 Onsolis 61 Application BLA 61 Pivotal Phase III 61 MKC# 61 AzaSite Plus 61 Locteron ® 61 Ferumoxytol 61 Medarex logo 61 Cetrorelix 61 Junovan 61 Evamist TM 61 post herpetic neuralgia PHN 61 Phase III Clinical Trial 61 sodium Injection 61 product GEM #S 61 Anturol 61 AMITIZA R 61 orthobiologic 61 inflammatory autoimmune diseases 61 Takeda Kyowa Hakko Kirin 61 Entereg R 61 aesthetic medicine BioLook 61 dipropionate 61 Levulan R 60 Rectogesic 60 PEGylation technology 60 PEG PAL PEGylated recombinant 60 Lipid Polymer Micelle LPM 60 ALN TTR 60 Frova R 60 Extended Release Tablets 60 RISPERDAL ® CONSTA ® 60 anticancer compound 60 Patient Enrollment 60 Ixempra 60 Harbor BioSciences 60 sodium phosphate dibasic anhydrous 60 REPEL CV 60 ZEGERID Capsules 60 Dapagliflozin 60 Elevess 60 Zyflo 60 diabetic macular edema DME